{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:43:05Z","timestamp":1758357785139,"version":"3.44.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92717","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:11:24Z","timestamp":1758291084000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Encephalopathy and Severe Hypercalcemia as the Initial Presentation of a Large Parathyroid Hormone-Related Protein (PTHrP)-Secreting Pancreatic Neuroendocrine Tumor: A Case Report"],"prefix":"10.7759","author":[{"given":"Katherine M","family":"Collamore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Jandir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Cruz Ponce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2015.10.007","article-title":"Islet cell tumors of the pancreas","volume":"45","author":"Amin S","year":"2016","unstructured":"Amin S, Kim MK. Islet cell tumors of the pancreas. Gastroenterol Clin North Am. 2016, 45:83-100. 10.1016\/j.gtc.2015.10.007","journal-title":"Gastroenterol Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.46883\/ONC.2020.3412.0548","article-title":"Pancreatic neuroendocrine tumor with humoral hypercalcemia and high tumor PD-L1 score","volume":"34","author":"Copur MS","year":"2020","unstructured":"Copur MS, Vargas L, Wedel W, Merani S, Cushman-Vokoun A, Drincic A. Pancreatic neuroendocrine tumor with humoral hypercalcemia and high tumor PD-L1 score. Oncology (Williston Park). 2020, 34:548-52. 10.46883\/ONC.2020.3412.0548","journal-title":"Oncology (Williston Park)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2023-0044","article-title":"Diagnosis and management of neuroendocrine tumours","volume":"23","author":"Cuthbertson DJ","year":"2023","unstructured":"Cuthbertson DJ, Shankland R, Srirajaskanthan R. Diagnosis and management of neuroendocrine tumours. Clin Med (Lond). 2023, 23:119-24. 10.7861\/clinmed.2023-0044","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.170600","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"7","author":"Mirrakhimov AE","year":"2015","unstructured":"Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci. 2015, 7:483-93. 10.4103\/1947-2714.170600","journal-title":"N Am J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn351","article-title":"Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival","volume":"19","author":"Halfdanarson TR","year":"2008","unstructured":"Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008, 19:1727-33. 10.1093\/annonc\/mdn351","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2592","article-title":"Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia","volume":"97","author":"Kanakis G","year":"2012","unstructured":"Kanakis G, Kaltsas G, Granberg D, Grimelius L, Papaioannou D, Tsolakis AV, \u00d6berg K. Unusual complication of a pancreatic neuroendocrine tumor presenting with malignant hypercalcemia. J Clin Endocrinol Metab. 2012, 97:E627-31. 10.1210\/jc.2011-2592","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari A","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al.. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017, 3:1335-42. 10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/apc-23-19","article-title":"Resolution of a rare case of hypercalcemia in a PTHrP-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres","volume":"7","author":"Dobra Neacsu E","year":"2024","unstructured":"Dobra Neacsu E, Mart\u00ednez Montalb\u00e1n E, Mart\u00ednez de Miguel B. Resolution of a rare case of hypercalcemia in a PTHrP-producing pancreatic neuroendocrine tumor using selective internal radiation therapy with 90Y microspheres. Ann Pancreat Cancer. 2024, 7:5. 10.21037\/apc-23-19","journal-title":"Ann Pancreat Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.665698","article-title":"Case report: unmasking hypercalcemia in patients with neuroendocrine neoplasms. Experience from six Italian referral centers","volume":"12","author":"Giannetta E","year":"2021","unstructured":"Giannetta E, Sesti F, Modica R, et al.. Case report: unmasking hypercalcemia in patients with neuroendocrine neoplasms. Experience from six Italian referral centers. Front Endocrinol (Lausanne). 2021, 12:665698. 10.3389\/fendo.2021.665698","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12101553","article-title":"What lies behind paraneoplastic hypercalcemia secondary to well-differentiated neuroendocrine neoplasms? A systematic review of the literature","volume":"12","author":"Giannetta E","year":"2022","unstructured":"Giannetta E, Sesti F, Modica R, et al.. What lies behind paraneoplastic hypercalcemia secondary to well-differentiated neuroendocrine neoplasms? A systematic review of the literature. J Pers Med. 2022, 12:1553. 10.3390\/jpm12101553","journal-title":"J Pers Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1197288","article-title":"Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): case report","volume":"13","author":"Pitts S","year":"2023","unstructured":"Pitts S, Mahipal A, Bajor D, Mohamed A. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): case report. Front Oncol. 2023, 13:1197288. 10.3389\/fonc.2023.1197288","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219692","article-title":"Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET)","volume":"2017","author":"Symington M","year":"2017","unstructured":"Symington M, Davies L, Kaltsas G, Weickert MO. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET). BMJ Case Rep. 2017, 2017:bcr2017219692. 10.1136\/bcr-2017-219692","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner W","year":"2016","unstructured":"Goldner W. Cancer-related hypercalcemia. J Oncol Pract. 2016, 12:426-32. 10.1200\/JOP.2016.011155","journal-title":"J Oncol Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2013.02.007","article-title":"Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases","volume":"13","author":"Milanesi A","year":"2013","unstructured":"Milanesi A, Yu R, Wolin EM. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases. Pancreatology. 2013, 13:324-6. 10.1016\/j.pan.2013.02.007","journal-title":"Pancreatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-023-04042-5","article-title":"Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report","volume":"17","author":"Behdadnia A","year":"2023","unstructured":"Behdadnia A, Jeddi M. Severe hypercalcemia due to metastatic pancreatic neuroendocrine tumor: a case report. J Med Case Rep. 2023, 17:400. 10.1186\/s13256-023-04042-5","journal-title":"J Med Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2025.111058","article-title":"Hypercalcemia due to PTHrp producing pancreas NET: a case report","volume":"128","author":"Br\u00fcckner F","year":"2025","unstructured":"Br\u00fcckner F, Maurer E, Bartsch DK, Schmitt M, Rinke A. Hypercalcemia due to PTHrp producing pancreas NET: a case report. Int J Surg Case Rep. 2025, 128:111058. 10.1016\/j.ijscr.2025.111058","journal-title":"Int J Surg Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-025-05074-9","article-title":"Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report","volume":"19","author":"Haimi M","year":"2025","unstructured":"Haimi M, Yang JW, Kremer R. Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report. J Med Case Rep. 2025, 19:54. 10.1186\/s13256-025-05074-9","journal-title":"J Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404447-acute-encephalopathy-and-severe-hypercalcemia-as-the-initial-presentation-of-a-large-parathyroid-hormone-related-protein-pthrp-secreting-pancreatic-neuroendocrine-tumor-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:11:25Z","timestamp":1758291085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404447-acute-encephalopathy-and-severe-hypercalcemia-as-the-initial-presentation-of-a-large-parathyroid-hormone-related-protein-pthrp-secreting-pancreatic-neuroendocrine-tumor-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.92717","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}